New advances and practical dimensions of optimizing management of acute coronary syndrome: evidence-based use of oral factor Xa inhibition to improve outcomes in patients with acute coronary syndrome (ACS) - Risk stratification, patient selection, and clinical pearls for oral factor Xa-based management
Event:
ESC CONGRESS 2014
Topic:
Post infarction period
Session type:
Satellite Symposium